| ORIGINAL ARTICLE |
|
| Year : 2017 | Volume
: 23
| Issue : 2 | Page : 207--211 |
Assessment of cancer-related fatigue among cancer patients receiving various therapies: A cross-sectional observational study
Raja Paramjeet Singh Banipal1, Harminder Singh2, Baltej Singh3
1 Department of Onco-radiation, Baba Farid University of Health Sciences, Faridkot, Punjab, India
2 Department of Pharmacology, Baba Farid University of Health Sciences, Faridkot, Punjab, India
3 Department of Bio-statics, Baba Farid University of Health Sciences, Faridkot, Punjab, India
Correspondence Address:
Harminder Singh
Department of Pharmacology, Baba Farid University of Health Sciences, G.G.S. Medical College, Faridkot - 151 203, Punjab
India
 Source of Support: None, Conflict of Interest: None  | Check |
DOI: 10.4103/IJPC.IJPC_135_16
Objective: The objective of this cross-sectional, noninterventional 3-month observational study was to analyze the prevalence of the cancer-related fatigue (CRF) in cancer patient populations with correlation of CRF with different treatment modalities. Materials and Methods: A descriptive study was carried out jointly by the pharmacology and oncology departments of a tertiary care center in the Malwa region of Punjab. The data collection was performed by administering the validated Brief Fatigue Inventory (BFI) after obtaining the informed consent. Results: One hundred and twenty-six cancer patients were recruited with the mean age of 49.13 years ± 14.35 (standard deviation). There are statistical correlations found between fatigue and chemotherapy agents such as vinblastine, dacarbazine, and cyclophosphamide. Conclusion: We observed that CRF is a symptom that is experienced by majority of cancer patients, irrespective of the diagnosis, or type of treatment received. In addition, assessing CRF before and after treatment will facilitate health-care practitioner to treat this symptom.
[FULL TEXT] [PDF]*
|
